KTTA (pasitheaclinics.com) Bozor qiymatining balans qiymatiga nisbati
Neyrofarmakologiyaga kirishning yuqori to'sig'i FDA ning qat'iy nazorati va sinovlarning yuqori xarajatlari bilan bog'liq. Bozor kapitalizatsiyasining buxgalteriya qiymatidan oshish darajasi tebranishlarni namoyish etadi, bunda 0.27 eng so'nggi metrika ko'rsatkichini ifodalaydi. Pasithea Therapeutics (KTTA) strategiyasi davolashga chidamli depressiyaga qarshi kurashishga qaratilgan, biroq savdolarning yo'qligi kompaniyani ventura kapitali investitsiyalariga bog'liq qilib qo'ygan.
%20Kapitallashuvning%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_KTTA_-_Pasithea-Therapeutics_-_Capitalization-to-Book-Value-Ratio "KTTA Pasithea Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 28.10.2026) | 👁️GURU.Markets👁️")
Pasithea Therapeutics (KTTA) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Pasithea Therapeutics|KTTA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati pasitheaclinics.com|KTTA - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Pasithea|KTTA - Uzoq muddatli majburiyatlar|Kompaniyaning qisqa muddatli qarzlari Pasithea Therapeutics
Fundamental baholash:KTTA Pasithea Therapeutics Corp
Investitsiya xatarlarini kamaytirish bozor narxini aktivlarning haqiqiy qiymati bilan aniq muvofiqlashtirishni talab qiladi. Yashil kimyo tamoyillarini joriy etayotgan biofarmatsevtika kompaniyasi Pasithea Therapeutics (KTTA) uchun bu laboratoriyalar qiymatini baholashda juda muhimdir. Pasithea Therapeutics (KTTA) uchun P/BV grafigini tahlil qilib, investor bozor kapitalizatsiyasining sof aktivlarga nisbatini ko'rishi mumkin. Ushbu koeffitsiyentning oshishi diskontning qisqarishidan dalolat beradi va ushbu narx harakati kapitaldan foydalanish samaradorligini belgilaydi.
Raqobatchilar tahlili
BIIB: Bozor kapitallashuvining balans qiymatiga nisbati|NBIX (neurocrine.com) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited (RGC)|Kapitallashuvning balans qiymatiga nisbati Axsome|ACADIA Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Xenon Corp XENE|Kapitallashuvning sof aktivlarga nisbati VKTX (Viking Therapeutics)|supernus.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Catalyst Pharmaceuticals, Inc. (CPRX)|DNLI: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati HRMY|BHVN (Biohaven Corp) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Amylyx Pharmaceuticals AMLX|Sof aktivlarga nisbatan bozor kapitallashuvi trevitherapeutics.com|Bozor kapitallashuvining balans qiymatiga nisbati PRAX|Bozor kapitallashuvining balans qiymatiga nisbati AVXL (Anavex)|Bozor qiymatining balans qiymatiga nisbati CBLL|Balans qiymatiga nisbatan bozor kapitallashuvi Prothena PRTA|Bozor kapitallashuvining balans qiymatiga nisbati ALEC (Alector Therapeutics)|annexonbio.com (ANNX) - Balans qiymatiga nisbatan bozor kapitallashuvi|OMER - Kapitallashuvning sof aktivlarga nisbati|Neurogene Inc (NGNE) - Bozor kapitallashuvining balans qiymatiga multiplikatori|ACIU - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Voyager Corp|Neumora Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti scilexholding.com (SCLX)|Bozor kapitallashuvining balans qiymatiga nisbati TVGN (Tevogen Bio)|ACOG - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Cognition Therapeutics, Inc. (CGTX)|Inhibikase Pharma (IKT) - Balans qiymatiga nisbatan bozor qiymati|SAVA - Kapitallashuvning sof aktivlarga nisbati|Assertio (ASRT) - Bozor kapitallashuvining balans qiymatiga multiplikatori|COYA - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati VistaGen Therapeutics Inc|Ovid Therapeutics Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti ABOS (Acumen Pharmaceuticals, Inc)|Bozor qiymatining balans qiymatiga nisbati CervoMed Inc.|Balans qiymatiga nisbatan bozor qiymati Alterity Therapeutics Ltd. ATHE|Clene Nanomedicine - Bozor kapitallashuvining balans qiymatiga nisbati|PEPG: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Jupiter Neurosciences (JUNS)|Relmada Corp (RLMD) - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati ANVS (Annovis Bio, Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti Grace Tx (GRCE)|Kapitallashuvning sof aktivlarga nisbati AIFF|Bozor kapitallashuvining balans qiymatiga nisbati anewmeds.com KLTO|Kapitallashuvning sof aktivlarga nisbati NeuroSense Therapeutics Ltd. (NRSN)|Bozor kapitallashuvining balans qiymatiga multiplikatori Reviva Pharmaceuticals, Inc. RVPH|Bozor kapitallashuvining balans qiymatiga nisbati MTVA (MetaVia, Inc.)|NRXS - Balans qiymatiga nisbatan bozor kapitallashuvi|HSDT (heliusmedical.com) - Bozor kapitallashuvining balans qiymatiga nisbati|PASG (Passage Bio) - Kapitallashuvning sof aktivlarga nisbati|NEUP: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi NERV|Bozor qiymatining balans qiymatiga nisbati ATHA|Bozor kapitallashuvining balans qiymatiga nisbati addextherapeutics.com ADXN|Kapitallashuvning sof aktivlarga nisbati Alzamend Neuro (ALZN)|CYCN - Bozor kapitallashuvining balans qiymatiga multiplikatori|Kapitallashuvning sof aktivlarga nisbati Protagenic PTIX|CRGT - Bozor kapitallashuvining balans qiymatiga multiplikatori|ATXI: Bozor kapitallashuvining balans qiymatiga nisbati|BCLI (brainstorm-cell.com) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Cara Therapeutics (CARA)|Kapitallashuvning balans qiymatiga nisbati Chromocell Therapeutics Corp|Eliem Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti intracellulartherapies.com ITCI|Kapitallashuvning sof aktivlarga nisbati LBPH (Longboard Pharmaceuticals)|marinuspharma.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati NKGen Biotech (NKGN)|NRBO: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati SAGE|SNPX (Synaptogenix, Inc) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Trevena, Inc. TRVN|Sof aktivlarga nisbatan bozor kapitallashuvi Vigil Neuro|Bozor kapitallashuvining balans qiymatiga nisbati WENA|Bozor kapitallashuvining balans qiymatiga nisbati CERE (Cerevel Therapeutics Inc)